| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases
|
Isasi, Carmen R.
|
|
2005
|
90 |
2 |
p. 105-112
|
artikel
|
| 2 |
A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer
|
Modi, Shanu
|
|
2005
|
90 |
2 |
p. 157-163
|
artikel
|
| 3 |
Clodronate treatment influences MMP-2 associated outcome in node positive breast cancer
|
Leppä, S.
|
|
2005
|
90 |
2 |
p. 117-125
|
artikel
|
| 4 |
Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death
|
Rakovitch, Eileen
|
|
2005
|
90 |
2 |
p. 139-148
|
artikel
|
| 5 |
Distinct breast cancer incidence and prognostic patterns in the NCI’s SEER program: suggesting a possible link between etiology and outcome
|
Anderson, William F.
|
|
2005
|
90 |
2 |
p. 127-137
|
artikel
|
| 6 |
Genetic polymorphisms of TGF-β1 & TNF-β and breast cancer risk
|
Lee, Kyoung-Mu
|
|
2005
|
90 |
2 |
p. 149-155
|
artikel
|
| 7 |
Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk
|
Langsenlehner, Uwe
|
|
2005
|
90 |
2 |
p. 113-115
|
artikel
|
| 8 |
Is stereotactic large-core needle biopsy beneficial prior to surgical treatment in BI-RADS 5 lesions?
|
Verkooijen, H. M.
|
|
2005
|
90 |
2 |
p. 191
|
artikel
|
| 9 |
Pathology of breast cancer in women with constitutional CHEK2 mutations
|
Huzarski, Tomasz
|
|
2005
|
90 |
2 |
p. 187-189
|
artikel
|
| 10 |
Primary docetaxel chemotherapy in patients with breast cancer: impact on response and survival
|
Heys, Steven D.
|
|
2005
|
90 |
2 |
p. 169-185
|
artikel
|
| 11 |
The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic
|
Kleibl, Zdenek
|
|
2005
|
90 |
2 |
p. 165-167
|
artikel
|
| 12 |
Updates on SABCS 2004 abstracts
|
|
|
2005
|
90 |
2 |
p. 193-214
|
artikel
|
Tijdschrift beschrijving